Interaction involving tadalafil and CYP3A4 inhibition by ritonavir

Scand J Infect Dis. 2011 Mar;43(3):239-40. doi: 10.3109/00365548.2010.526139. Epub 2010 Oct 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects*
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Antiretroviral Therapy, Highly Active / methods
  • Carbolines / administration & dosage
  • Carbolines / adverse effects*
  • Cytochrome P-450 CYP3A / deficiency
  • Cytochrome P-450 CYP3A Inhibitors*
  • Drug Interactions*
  • HIV Infections / drug therapy
  • Humans
  • Male
  • Priapism / chemically induced
  • Ritonavir / administration & dosage
  • Ritonavir / adverse effects*
  • Tadalafil

Substances

  • Anti-HIV Agents
  • Carbolines
  • Cytochrome P-450 CYP3A Inhibitors
  • Tadalafil
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Ritonavir